Molecular analysis revealed ALK-negative, ROS positive, epidermal growth factor receptor (EGFR) mutant (Exon 21 L858R point mutation), and positive PD-L1 30%, all supporting a lung adenocarcinoma diagnosis. Here, EGFR is linked to lung adenocarcinoma.